Fetal and maternal outcomes of gestational thrombocytopenia: an observational study

Tapasvi Kadiyala; Lopamudra B. John; Karthikeyan Kadirvel

doi:10.18203/2320-1770.ijrcog20243927

Authors

Tapasvi Kadiyala Department of Obstetrics and Gynecology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India
Lopamudra B. John Department of Obstetrics and Gynecology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India
Karthikeyan Kadirvel Department of Paediatrics, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243927

Keywords:

Gestational thrombocytopenia, Maternal and fetal outcomes, Neonatal complications

Abstract

Background: The most common cause of pregnancy-related thrombocytopenia is gestational thrombocytopenia. There is a paucity of studies showing the effect of GT in mothers and neonates in the Indian population. So the present study was done to find out maternal and fetal outcomes of gestational thrombocytopenia in a tertiary care centre.

Methods: 92 pregnant women diagnosed with gestational thrombocytopenia with platelet count of less than 150000 were enrolled. Women with hypertensive disorders, autoimmune diseases, acute and chronic kidney disease, infections like dengue fever were excluded. The participants were evaluated by taking detailed history, clinical examination and routine investigations like complete blood count. Demographic variables like age, parity and clinical details like when she was diagnosed with gestational thrombocytopenia and what was the platelet count were noted. Complete blood count-platelets were measured at the time of diagnosis. Patients were followed through the pregnancy until delivery, various maternal factors were observed like oligohydramnios, IUGR, Antepartum hemorrhage, mode of delivery, post-delivery complications like PPH, incision site hematoma. Neonatal outcomes studied were APGAR, birth weight, neonatal thrombocytopenia and NICU admission.

Results: There was no positive correlation between mothers with gestational thrombocytopenia and adverse maternal, neonatal outcomes (age, liquor abnormalities, IUGR, mode of delivery, APH, PPH, incision hematoma, neonatal thrombocytopenia, APGAR, birth weight, NICU admissions).

Conclusions: It’s concluded that women with gestational thrombocytopenia do not have any adverse antenatal, perinatal, intrapartum, postnatal and neonatal complications.

Metrics

Metrics Loading ...

References

Cortes GA, Moore MJ, El-Nakeep S. Physiology, Von Willebrand Factor. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

Ciobanu AM, Colibaba S, Cimpoca B, Peltecu G, Panaitescu AM. Thrombocytopenia in Pregnancy. Mædica. 2016;11(1):55-60.

Jinna S, Khandhar PB. Thrombocytopenia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet Counts during Pregnancy. N Engl J Med. 2018;379(1):32-43.

Habas E, Rayani A, Alfitori G, Eldin Ahmed G, Elzouki ANY. Gestational Thrombocytopenia: A Review on Recent Updates. Cureus. 2022;14(3):e23204.

Pishko AM, Marshall AL. Thrombocytopenia in pregnancy. Hematol Am Soc Hematol Educ Program. 2022;2022(1):303-11.

Bergmann F, Rath W. The differential diagnosis of thrombocytopenia in pregnancy. Dtsch Ärztebl Int. 2015;112(47):795-802.

Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95(1):29-33.

Myers B. Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol. 2012;158(1):3-15.

10. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood. 1992;80(11):2697-714.

Chauhan V, Gupta A, Mahajan N, Vij A, Kumar R, Chadda A. Maternal and fetal outcome among pregnant women presenting with thrombocytopenia. Int J Reprod Contracept Obstet Gynecol. 2016;2736-43.

Borhany M, Abid M, Zafar S, Zaidi U, Munzir S, Shamsi T. Thrombocytopenia in pregnancy: identification and management at a reference center in Pakistan. Cureus. 2022;14(3):e23490.

Elveđi-Gašparović V, Beljan P, Gverić-Ahmetašević S, Schuster S, Škrablin S. Fetal-maternal complications and their association with gestational thrombocytopenia. Ginekol Pol. 2016;87(6):454-9.

Taş B, Günenc O. Maternal and fetal outcomes of gestational thrombocytopenia. Duzce Med J. 2022;24(3):282-6.

Kashyap R, Garg A, Pradhan M. Maternal and fetal outcomes of pregnancy in patients with immune thrombocytopenia. J Obstet Gynaecol India. 2021;71(2):124-30.

Wang X, Xu Y, Luo W, Feng H, Luo Y, Wang Y, et al. Thrombocytopenia in pregnancy with different diagnoses: Differential clinical features, treatments, and outcomes. Medicine (Baltimore). 2017;96(29):e7561.

Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, et al. Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):163-8.

Artunç Ülkümen B, Aktenk F, Baytur Y. Fetomaternal outcomes of cases with thrombocytopenia during pregnancy. J Kartal Tra Res Hospi. 2014;25(2).

Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329(20):1463-6.